logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ANTENGENE-B (06996) repurchased 107,000 shares on October 28 for approximately HK$303,800.

date
18:27 28/10/2026
avatar
GMT Eight
ANTENGENE-B (06996) announced that on October 28, 2026, it repurchased 107,000 shares for approximately HK$303,800.
ANTENGENE-B (06996) announced that on October 28, 2026, it repurchased 107,000 shares for approximately HK$303,800.
Related Articles
HK Stock
NAYUKI (02150) repurchased 940,000 shares on October 28 for HK$641,000.
HK Stock
SINOPEC SSC (01033) reported net profit attributable to shareholders of approximately RMB711 million for the first three quarters, up 6.2% year on year.
US Stock
Biogen (BIIB.US) Q3 results beat expectations, with strong sales of rare disease drugs.
NAYUKI (02150) repurchased 940,000 shares on October 28 for HK$641,000.
HK Stock
SINOPEC SSC (01033) reported net profit attributable to shareholders of approximately RMB711 million for the first three quarters, up 6.2% year on year.
HK Stock
Biogen (BIIB.US) Q3 results beat expectations, with strong sales of rare disease drugs.
US Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.